Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight

Johnson & Johnson proposes a $5.5 billion settlement to resolve remaining talc-related lawsuits claiming its products caused ovarian cancer. The settlement requires at least 95% participation from claimants and includes an initial $3 billion payment next year, with no further payments until 2028. The company previously settled most claims related to mesothelioma, consumer protection, and talc-supplier disputes.